Search - tctmd.com

Displaying 741 - 760 of 1554

Sort: Relevancy | Date

Presentation TCT 2019

The Case for Functional (Not Anatomic) Complete Revascularization: Preview of FAME 3

Presenter: William Fearon

September 27, 2019

Presentation TCT 2019

While Awaiting More Clinical Trial Data: Real-World Approaches to Cardiogenic Shock and Hemodynamic Support

Presenter: Alexander Truesdell

September 27, 2019

Presentation TCT 2019

SECURE-PCI: 1-Year Outcomes From a Randomized Trial of a Loading Dose of Atorvastatin in Patients With ACS and Planned PCI

Presenter: Otavio Berwanger

September 27, 2019

Presentation TCT 2019

Physiological Guidance in Multivessel Disease PCI: Lessons Learned From SYNTAX II 3-Year Follow

Presenter: Javier Escaned

September 27, 2019

Presentation TCT 2019

Long-Term Outcomes With Physiology Guidance: Increased Risk for MI Among Patients Treated Medically?

Presenter: Nils Johnson

September 27, 2019

Presentation TCT 2019

2-Year Outcome Data From DEFINE-FLAIR and Swedeheart: A Critical Appraisal

Presenter: Matthias Götberg

September 27, 2019

Presentation TCT 2019

ABSORB 5-Year Pooled Analysis: Improving Very Late Outcomes of the Absorb Bioresorbable Scaffold in Coronary Artery Disease From 4 Randomized Trials

Presenter: Gregg Stone

September 27, 2019

Presentation TCT 2019

MAGSTEMI: A Randomized Trial of a Magnesium-Based Sirolimus-Eluting Resorbable Scaffold vs. Metallic DES in Patients With STEMI

Presenter: Manel Sabate

September 27, 2019

Presentation TCT 2019

PROTECCT: A Randomized Trial of Emergency CTA in Patients With Possible ACS and Intermediate Levels of HS-Troponin Elevation

Presenter: Divaka Perera

September 27, 2019

Presentation TCT 2019

Designing Controlled Trials for Shock Devices: Population Targets and Safety and Effectiveness Considerations

Presenter: Anthony Gershlick

September 27, 2019

Presentation TCT 2019

CIT-RESOLVE: A Randomized Trial of Sidebranch Protection in Patients With Coronary Bifurcations and High Predicted Risk of Sidebranch Occlusion

Presenter: Bo Xu

September 27, 2019

Presentation TCT 2019

Industry Perspectives on Controlled Trials for Shock Devices

Presenter: Seth Bilazarian

September 27, 2019

Presentation TCT 2019

PICCOLETO II: 6-Month Clinical and Angiographic Findings From a Randomized Trial of Drug-Coated Balloons vs. Drug-Eluting Stents for Treatment of Small Vessel Coronary Artery Disease

Presenter: Bernardo Cortese

September 27, 2019

Presentation TCT 2019

LUTONIX BTK Diabetes: Outcomes From a Randomized Trial of a Drug-Coated Balloon vs. Standard Angioplasty in Diabetic Patients With Below-the-Knee Disease

Presenter: Marianne Brodmann

September 27, 2019

Presentation TCT 2019

Industry View on Controlled Trials for Heart Failure and Shock Devices

Presenter: William Abraham

September 27, 2019

Presentation TCT 2019

Devices for Heart Failure: FDA Perspectives on Trial Designs and Endpoints

Presenter: Bram Zuckerman

September 27, 2019

Presentation TCT 2019

Answers and Questions After AUGUSTUS

Presenter: C. Michael Gibson

September 27, 2019

Presentation TCT 2019

RADIANCE-HTN SOLO: In-Depth Analysis at 6 Months After Medication Titration and Review of RADIANCE-HTN Global Clinical Trial Program

Presenter: Ajay Kirtane

September 27, 2019

Presentation TCT 2019

Balancing Efficacy and Safety in Trial Interpretation

Presenter: David Cohen

September 27, 2019

Presentation TCT 2019

Drug-Coated Balloons in the Periphery: Red Alert or Red Herring?

Presenter: Eric Secemsky

September 27, 2019

Advertisement

The Case for Functional (Not Anatomic) Complete Revascularization: Preview of FAME 3

While Awaiting More Clinical Trial Data: Real-World Approaches to Cardiogenic Shock and Hemodynamic Support

SECURE-PCI: 1-Year Outcomes From a Randomized Trial of a Loading Dose of Atorvastatin in Patients With ACS and Planned PCI

Physiological Guidance in Multivessel Disease PCI: Lessons Learned From SYNTAX II 3-Year Follow

Long-Term Outcomes With Physiology Guidance: Increased Risk for MI Among Patients Treated Medically?

2-Year Outcome Data From DEFINE-FLAIR and Swedeheart: A Critical Appraisal

ABSORB 5-Year Pooled Analysis: Improving Very Late Outcomes of the Absorb Bioresorbable Scaffold in Coronary Artery Disease From 4 Randomized Trials

MAGSTEMI: A Randomized Trial of a Magnesium-Based Sirolimus-Eluting Resorbable Scaffold vs. Metallic DES in Patients With STEMI

PROTECCT: A Randomized Trial of Emergency CTA in Patients With Possible ACS and Intermediate Levels of HS-Troponin Elevation

Designing Controlled Trials for Shock Devices: Population Targets and Safety and Effectiveness Considerations

CIT-RESOLVE: A Randomized Trial of Sidebranch Protection in Patients With Coronary Bifurcations and High Predicted Risk of Sidebranch Occlusion

Industry Perspectives on Controlled Trials for Shock Devices

PICCOLETO II: 6-Month Clinical and Angiographic Findings From a Randomized Trial of Drug-Coated Balloons vs. Drug-Eluting Stents for Treatment of Small Vessel Coronary Artery Disease

LUTONIX BTK Diabetes: Outcomes From a Randomized Trial of a Drug-Coated Balloon vs. Standard Angioplasty in Diabetic Patients With Below-the-Knee Disease

Industry View on Controlled Trials for Heart Failure and Shock Devices

Devices for Heart Failure: FDA Perspectives on Trial Designs and Endpoints

Answers and Questions After AUGUSTUS

RADIANCE-HTN SOLO: In-Depth Analysis at 6 Months After Medication Titration and Review of RADIANCE-HTN Global Clinical Trial Program

Balancing Efficacy and Safety in Trial Interpretation

Drug-Coated Balloons in the Periphery: Red Alert or Red Herring?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content